Evidence map›Paper›PMID 39143532›Full record

ArticleJournal of nanobiotechnology2024

M2 macrophage-polarized anti-inflammatory microneedle patch for accelerating biofilm-infected diabetic wound healing via modulating the insulin pathway.

Yushan Yang, Limin Fan, Jingsi Jiang, Jiuyuan Sun, Liangyi Xue, Xiaoyi Ma, Le Kuai, Bin Li, Yongyong Li

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yushan Yang *The Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China.
Limin Fan *The Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China.
Jingsi Jiang *Shanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University, Shanghai, 200443, China.
Jiuyuan SunThe Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China.
Liangyi XueThe Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China.
Xiaoyi MaThe Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China.
Le KuaiDepartment of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Bin LiShanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University, Shanghai, 200443, China. lib@shskin.com.
Yongyong LiThe Institute for Biomedical Engineering & Nano Science, School of Medicine, Shanghai Skin Disease Hospital of Tongji University, Tongji University, Shanghai, 200092, China. yongyong_li@tongji.edu.cn.

Funding

Category A CACM-2021-QNRC2-A10Health Young Talents of Shanghai Municipal Health Commission 2022YQ026National Natural Science Foundation of China (No. 82374444Sci-Tech Innovation 2030-Major Project of Brain science and brain-inspired intelligence technology No. 2021ZD0202003Shanghai Dermatology Research Center No. 2023ZZ02017Shanghai Science and Technology Development Funds (Sailing Program) (No. 23YF1439800)Shanghai Skin Disease Hospital demonstration research ward project No. SHDC2023CRW009Talent Program of Shanghai Municipal Health Commission (No. 2022XD052)Xinglin Youth Scholar of Shanghai University of Traditional Chinese Medicine No. RY411.33.10Youth Talent Promotion Project of China Association of Traditional Chinese Medicine (2021-2023
6 · The paper itself

Abstract

Macrophages play a pivotal role in the healing of diabetic ulcers. The sustained elevation of glucose levels damages the insulin signaling pathway in macrophages, leading to dysfunctional macrophages that struggle to transition from pro-inflammatory (M1) to reparative (M2) states. Therefore, modulating macrophage inflammatory responses via the insulin pathway holds promise for diabetic ulcer treatment. Additionally, the presence of biofilm impedes drug penetration, and the resulting immunosuppressive microenvironment exacerbates the persistent infiltration of pro-inflammatory M1 macrophages. Therefore, we designed an array of dissolvable microneedle (denoted as NPF@MN) loaded with self-assembled nanoparticles that could deliver NPF nanoparticles, acid-sensitive NPF-releasing Protocatechualdehyde (PA) with hypoglycemic and insulin-like effects, regulating macrophage polarization to an anti-inflammatory M2 phenotype. Additionally, this study extensively examined the mechanism by which NPF@MN accelerates the healing of diabetic ulcers through the activation of the insulin signaling pathway. Through RNA-seq and GSEA analysis, we identified a reduction in the expression of pathway-related factors such as IR, IRS-1, IRS-2, and SHC. Our work presents an innovative therapeutic approach targeting the insulin pathway in diabetic ulcers and underscores its translational potential for clinical management.

Indexed as

BiofilmsInsulinMacrophagesNeedlesSignal TransductionWound HealingAnimalsAnti-Inflammatory AgentsDiabetes Mellitus, ExperimentalMaleMiceMice, Inbred C57BLNanoparticlesRAW 264.7 CellsAnti-Inflammatory AgentsInsulinBiofilmDiabetic ulcers healingInsulin pathwayMacrophageMicroneedle

Identifiers

PMID39143532
PMCPMC11323363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.